04/02/2026
NEW! The Canadian Thoracic Society (CTS) has released a new position statement outlining screening recommendations for latent and active infections prior to initiating immunosuppression in patients with interstitial lung disease (ILD). Read here: https://www.tandfonline.com/doi/full/10.1080/24745332.2026.2632675